Patent Law Weblog
recent posts
- Judicial Conduct and Disability Committee Has Its Say, Denies Judge Newman’s Latest Request for Review
- PTAB Issues Judgment on Priority in CRISPR Interference
- Parties File Supplemental Priority Statements in CRISPR Interference
- Why the Alice Test is Stupid, Part V: The Goalposts Keep Moving
- Meanwhile, Back at the PTAB with CRISPR – Update
about
Month: September 2018
-
September 23-25, 2018 – Annual Meeting (Intellectual Property Owners Association) – Chicago, IL September 24, 2018 – Biotechnology/chemical/pharmaceutical (BCP) customer partnership meeting (U.S. Patent and Trademark Office) – Alexandria, VA September 26, 2018 – "IP Audit Checklist: Best Practices to Identify, Protect, Monetize and Enforce University IP Assets" (Technology Transfer Tactics) – 1:00 pm to…
-
The Intellectual Property Owners Association (IPO) will offer a one-hour webinar entitled "Biosimilars in the Antitrust Spotlight: Patent Litigation and Settlement" on October 4, 2018 from 2:00 to 3:00 pm (ET). Nicholas Mitrokostas of Goodwin Procter LLP, Richard Mortimer of Anaylsis Group, and Michael Perry of Baker Botts LLP will discuss: • The likely shape…
-
Oppedahl Patent Law Firm LLC will be offering an in-person PCT Seminar on October 16-18, 2018 in Redwood City, CA. Carl Oppedahl of Oppedahl Patent Law Firm LLC will address the following: I. Strategic topics: • Whether to use PCT or Paris Convention. • Choosing wisely when picking a Receiving Office. • Choosing wisely when…
-
Strafford will be offering a webinar entitled "Patent Term Adjustments and Extensions: Leveraging Recent Decisions and USPTO Rule Changes" on October 11, 2018 from 1:00 to 2:30 pm (EDT). Thomas L. Irving, Jill K. MacAlpine, and Charles E. Van Horn of Finnegan Henderson Farabow Garrett & Dunner will guide IP counsel in calculating patent term…
-
The John Marshall Law School Center for Intellectual Property, Information & Privacy Law will be hosting an IP Executive Seminar on "Standard Essential Patents: What Every IP Attorney and In-house Counsel Should Know" from 9:00 am to 4:30 pm on October 12, 2018 in Chicago, IL. The program, which will be presented by Graham Bell…
-
Strafford will be offering a webinar entitled "Negotiating IP Rights in Industry Sponsored Research Agreements — Structuring Ownership, Licensing, Assignment, Confidentiality, Publication and Use Provisions" on October 16, 2018 from 1:00 to 2:30 pm (EDT). Jeffrey D. Morton of Snell & Wilmer will guide counsel on negotiating and structuring industry sponsored research agreements (SRAs) to…
-
By Kevin E. Noonan — The Federal Circuit reversed a finding of non-obviousness in a Patent Trial and Appeal Board decision in an inter partes review, in an opinion handed down Monday in E. I. du Pont de Nemours & Co. v. Synvina C.V. The patent was directed to methods for oxidizing 5-hydroxymethylfurfural or derivatives…
-
By John E. Conour — Even with billions of dollars of funding and the cumulative knowledge and experience of over a hundred years of experimental pharmacology, de novo discovery of effective and safe therapeutics remains a costly and risky endeavor. The number of unsuccessful attempts to obtain Food and Drug Administration (FDA) approval of drugs…
-
By Kevin E. Noonan — The orange clownfish, Amphiprion percula, is an important denizen of many reef systems (and, thanks to Disney, Pixar, and Ellen Degeneris, one of the most famous fishes since the Billy Bass). One of thirty species of anemonefishes in the family of damselfishes, the orange clownfish is found in northern Australia,…
-
By Kevin E. Noonan — The varying appellate fortunes of patentees regarding the question of obviousness is illustrated nicely in the Federal Circuit decision in Orexo AB v. Actavis Elizabeth LLC handed down earlier this month. The statute, 35 U.S.C. § 103, was intended to tether the question of obviousness to the prior art (and…
Patent Docs 